Free Trial

BioSig Technologies Q2 2024 Earnings Report

BioSig Technologies logo
$1.13 -0.03 (-2.59%)
As of 03:58 PM Eastern

BioSig Technologies EPS Results

Actual EPS
-$0.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioSig Technologies Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioSig Technologies Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

BioSig Technologies Earnings Headlines

Outperform BTC without owning any crypto?
I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free…
See More BioSig Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioSig Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioSig Technologies and other key companies, straight to your email.

About BioSig Technologies

BioSig Technologies (NASDAQ:BSGM), together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

View BioSig Technologies Profile

More Earnings Resources from MarketBeat